Anu Anttonen
Impact in
- Cell Biology top 5%
- Proteoglycans and glycosaminoglycans research
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research
Papers in
-
- Glycosylation and Glycoproteins Research 3
- Angiogenesis and VEGF in Cancer 1
-
- Proteoglycans and glycosaminoglycans research 5
- Co-authors
- Heikki Joensuu (7 shared papers)M Kajanti (2 shared papers)Markku Jalkanen (2 shared papers)Päivi Heikkilä (2 shared papers)Pia Heikkilä (2 shared papers)Petri Salvén (1 shared paper)Sirpa Leppä (2 shared papers)Minna Eriksson (1 shared paper)
- Journals
- Physics and Imaging in Radiation Oncology (3 papers)Acta Oncologica (2 papers)Lung Cancer (2 papers)Cancer Medicine (1 paper)BMC Palliative Care (1 paper)
- Partner nations
- FinlandUnited States
In The Last Decade
Anu Anttonen
16 papers receiving 515 citations
Peers
Comparison fields: 5 of 61
- Cell Biology 253
- Immunology and Allergy 43
- Cancer Research 99
- Otorhinolaryngology 20
- Molecular Biology 273
Countries citing papers authored by Anu Anttonen
This map shows the geographic impact of Anu Anttonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anu Anttonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anu Anttonen more than expected).
Fields of papers citing papers by Anu Anttonen
This network shows the impact of papers produced by Anu Anttonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anu Anttonen. The network helps show where Anu Anttonen may publish in the future.
Co-authors
The 25 scholars most cited alongside Anu Anttonen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer. | 2002 | 133 |
| 2 | Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. | 1997 | 118 |
| 3 | 1999 | 116 | |
| 4 | 2001 | 71 | |
| 5 | 2003 | 36 | |
| 6 | 2022 | 10 | |
| 7 | 2006 | 9 | |
| 8 | 2023 | 8 | |
| 9 | 2025 | 4 | |
| 10 | 2025 | 3 | |
| 11 | [Treatment of esophageal cancer]. | 2014 | 3 |
| 12 | 2023 | 3 | |
| 13 | 2023 | 2 | |
| 14 | 2022 | 2 | |
| 15 | 2022 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2024 | 0 | |
| 18 | 2023 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2024 | 0 |
About Anu Anttonen
Anu Anttonen is a scholar working on Molecular Biology, Cell Biology, Oncology, Public Health, Environmental and Occupational Health and Surgery, having authored 20 papers that have together received 520 indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (5 papers), Glycosylation and Glycoproteins Research (3 papers), Palliative Care and End-of-Life Issues (3 papers), Boron Compounds in Chemistry (2 papers), Multiple and Secondary Primary Cancers (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Cancer Genomics and Diagnostics (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Cell Biology (253 citations), Immunology and Allergy (43 citations), Cancer Research (99 citations), Otorhinolaryngology (20 citations) and Molecular Biology (273 citations). Anu Anttonen has collaborated with scholars based in Finland and United States. Frequent co-authors include Heikki Joensuu, M Kajanti, Markku Jalkanen, Päivi Heikkilä, Pia Heikkilä, Petri Salvén, Sirpa Leppä, Minna Eriksson, Riitta Mäkitaro and Henrik Alfthan. Their work appears in journals such as Physics and Imaging in Radiation Oncology, Acta Oncologica, Lung Cancer, Cancer Medicine and BMC Palliative Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.